作为血管扩张剂的类化合物:一篇评论
Ayoub Amssayef1, Mohamed Eddouks1
1Team of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of Meknes, BP 509, Boutalamine, Errachidia, Morocco.
Current pharmaceutical design
|August 10, 2023
概括
选择的类化合物通过改善血管功能,显示出有希望的血管扩展作用,用于治疗高血压和心血管疾病. 这些天然化合物通过各种机制提供潜在的治疗益处.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
- 自然产品 化学 化学
背景情况:
- 高血压的病理生理学包括内皮功能障碍和血管扩张障碍.
- 来自自然产品的类化合物正在探索新的血管扩展剂.
研究的目的:
- 审查一些精选的类化合物的血管扩张作用的活体和体外研究.
- 阐明这些类化合物的血管扩张作用背后的机制.
主要方法:
- 关于ex-vivo和in-vitro研究的文献综述.
- 对类化合物的分析,包括柏柏林,西诺因和素.
- 检查对各种血管模型和细胞类型的影响.
主要成果:
- 精选的类化合物在中腔,心动脉和冠状动脉,大动脉和培养细胞中表现出血管扩张.
- 血管扩张通过内皮依赖和独立的途径发生,涉及eNOS/NO/sGC/cGMP,通道和通道.
- 类化合物通过减少氧化应激,内分泌网膜应激和炎症来保护内皮功能.
结论:
- 类化合物表现出显著的血管扩张性质和对内皮功能的保护作用.
- 这些天然化合物代表了对心血管疾病,特别是高血压的有希望的治疗途径.
关键词:
血管扩张剂是一种血管扩张剂.类化合物是一种类化合物.(Ca2+) 通道中的.eNOS/NO/sGC/cGMP通道中的一个.这种高血压,高血压.(K+) 通道中的 (K+)血管内皮的血管内皮.血管光滑肌肉的肌肉.更多相关视频
相关概念视频
Antihypertensive Drugs: Vasodilators
566
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
566
Antianginal Drugs: Nitrates and β-Blockers
645
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
645
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
561
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
561
Heart Failure Drugs: β-Blockers
364
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
364
Antihypertensive Drugs: Action of Calcium Channel Blockers
568
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
568
Adrenergic Agonists: Therapeutic Classification
861
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
861


